Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multidisciplinary model for implementation of nephrogenetics in CKD outpatients: a clinical and data-driven perspective.

Journal of nephrology·2026
Same author

IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant.

Nephrology (Carlton, Vic.)·2025
Same author

Structural Diversity and Dynamics of Metabotropic Glutamate Receptor/Beta-Arrestin Coupling.

bioRxiv : the preprint server for biology·2025
Same author

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis.

ESC heart failure·2024
Same author

A targeted proteomics approach to amyloidosis typing.

Clinical mass spectrometry (Del Mar, Calif.)·2024
Same author

Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.

European journal of preventive cardiology·2024

Related Experiment Video

Updated: Jun 2, 2026

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

[Atherosclerosis: a polidistrectual disease].

Claudio Rapezzi1, Pamela Gallo

  • 1Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna. claudio.rapezzi@unibo.it

Giornale Italiano Di Cardiologia (2006)
|April 16, 2011
PubMed
Summary

Atherosclerosis presents many unanswered questions regarding arterial wall changes and disease distribution. This review explores clinical implications in cardiology, neurology, and vascular intervention contexts.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Clinical Atherosclerosis Research

Context:

  • Atherosclerosis remains a complex systemic disease with unresolved questions regarding its varied clinical manifestations.
  • Understanding the reasons behind arterial wall dilatation versus lumen narrowing is crucial.
  • Investigating the preferential involvement of specific vascular beds and lesion localization is essential for patient management.

Purpose:

  • To review the major clinical implications of unresolved issues in atherosclerosis.
  • To explore the diagnostic and therapeutic challenges in specific clinical scenarios.
  • To provide insights into the management of patients with complex atherosclerotic disease.

Summary:

  • This paper addresses key unanswered questions in atherosclerosis, focusing on arterial remodeling and disease distribution.

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

  • It examines the clinical relevance of these uncertainties in three distinct patient scenarios: post-neurological events, vascular interventions, and renal artery stenosis evaluation.
  • The review synthesizes current knowledge and highlights areas requiring further investigation.

    • Impact:

    • Improved understanding of atherosclerosis heterogeneity can lead to more personalized patient care.
    • This review aids clinicians in managing complex cases involving multiple vascular territories.
    • It underscores the need for continued research into the fundamental mechanisms of atherosclerotic disease progression.